Or. Admin. R. 333-055-0015 - Educational Training

Current through Register Vol. 61, No. 4, April 1, 2022

(1) Individuals to be trained to administer glucagon and school personnel to be trained to administer a medication that treats a student who has adrenal insufficiency and who is experiencing symptoms of adrenal crisis based on the student's health plan must be trained by:
(a) A physician licensed under ORS Chapter 677;
(b) A nurse practitioner licensed under ORS Chapter 678; or
(c) A registered nurse licensed under ORS Chapter 678.
(2) Individuals to be trained to administer epinephrine must be trained by:
(a) A physician licensed under ORS Chapter 677;
(b) A nurse practitioner licensed under ORS Chapter 678;
(c) A registered nurse licensed under ORS Chapter 678 as assigned by a supervising professional to teach the OHA-Public Health Division Treatment of Severe Allergic Reaction training and distributes a Certificate of Completion and Authorization to Obtain Epinephrine in accordance with OAR 333-055-0030(1); or
(d) A paramedic as delegated by an EMS Medical Director defined in OAR chapter 333, division 265.
(3) The training described in sections (1) and (2) of this rule must follow the Oregon Health Authority, Public Health Division training protocol, or an Authority approved equivalent. The Public Health Division approved training protocol for emergency glucagon providers is available on the Internet at http://healthoregon.org/diabetes. The training protocols for the treatment of severe allergic reaction or treatment of adrenal crisis are available on the Internet at http://healthoregon.org/ems.

Notes

Or. Admin. R. 333-055-0015
HD 10-1982, f. & ef. 5-25-82; HD 23-1990(Temp), f. & cert. ef. 8-15-90; OHD 7-1998, f. & cert. ef. 7-28-98; PH 10-2004, f. & cert. ef. 3-23-04; PH 14-2012, f. & cert. ef. 9-19-12; PH 3-2016, f. & cert. ef. 2/8/2016

Stat. Auth.: ORS 433.810

Stats. Implemented: ORS 433.815 & 433.817

The following state regulations pages link to this page.



State regulations are updated quarterly; we currently have two versions available. Below is a comparison between our most recent version and the prior quarterly release. More comparison features will be added as we have more versions to compare.